Mollà M - Search Results

1

Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group.

Eraso A, Sanz J, Mollà M, Reyes V, Pedro A, Arenas M, Martinez E, Ballester R, Cambra MJ, García V, Prades JL, Borras JM, Algara M. Eraso A, et al. Among authors: molla m. Clin Transl Oncol. 2022 Aug;24(8):1580-1587. doi: 10.1007/s12094-022-02798-8. Epub 2022 Feb 21. Clin Transl Oncol. 2022. PMID: 35190961 Free PMC article.

2

Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients.

Cambra MJ, Moreno F, Sanz X, Anglada L, Mollà M, Reyes V, Arenas M, Pedro A, Ballester R, García V, Casals J, Cusidó M, Jimenez C, Escribà JM, Macià M, Solé JM, Arcusa A, Seguí MA, Gonzalez S, Farrús B, Biete A. Cambra MJ, et al. Among authors: molla m. Clin Transl Oncol. 2020 May;22(5):670-680. doi: 10.1007/s12094-019-02168-x. Epub 2019 Jul 1. Clin Transl Oncol. 2020. PMID: 31264148

3

Management of breast ductal carcinoma in situ in Catalonia, Spain: Results from the Grup Oncologic Calalà-Occità-Catalonia survey with 9-year follow up.

Cambra MJ, Farrús B, Moreno F, Anglada L, Arenas M, Ballester R, Casals J, Cusidó M, García V, Gutiérrez C, Mollà M, Pedro A, Reyes V, Sanz X. Cambra MJ, et al. Among authors: molla m. Breast. 2017 Oct;35:196-202. doi: 10.1016/j.breast.2017.08.002. Epub 2017 Aug 11. Breast. 2017. PMID: 28806663

4

Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in Catalonia, Spain.

Borras JM, Font R, Solà J, Macia M, Tuset V, Arenas M, Eraso A, Verges R, Farré N, Pedro A, Mollà M, Algara M, Solé JM, Mira M, Espinàs JA. Borras JM, et al. Among authors: molla m. Radiother Oncol. 2020 Oct;151:200-205. doi: 10.1016/j.radonc.2020.08.002. Epub 2020 Aug 6. Radiother Oncol. 2020. PMID: 32771615 Free article.

5

Chronic toxicity and long-term outcome in intraoperative electron radiotherapy as boost followed by whole-breast irradiation.

Oses G, Cases C, Valduvieco I, Farrús B, Alonso I, Caparrós X, Mases J, Muñoz-Guglielmetti D, Biete A, Castro C, Escudero E, Molina M, Herreros A, Saez J, Mollà M. Oses G, et al. Among authors: molla m. Clin Transl Oncol. 2021 Aug;23(8):1593-1600. doi: 10.1007/s12094-021-02555-3. Epub 2021 Feb 3. Clin Transl Oncol. 2021. PMID: 33534078

6

Analgesic effects of low-dose radiotherapy in greater trochanteric pain syndrome: results in a clinical series of 155 patients with recurrent or refractory symptoms.

Biete A, Valduvieco I, Cases C, Fernández-Valencia J, Moreno LA, Del Amo M, Rovirosa Á, Oses G, Mases J, Mollà M. Biete A, et al. Among authors: molla m. Clin Transl Oncol. 2022 May;24(5):846-853. doi: 10.1007/s12094-021-02730-6. Epub 2021 Nov 22. Clin Transl Oncol. 2022. PMID: 34807401

7

Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.

Mollà M, Saez J, Ramos M, Giraldo A, Seoane A, Andreu J, Simó M, Giralt J. Mollà M, et al. Br J Radiol. 2016 Jun;89(1062):20150824. doi: 10.1259/bjr.20150824. Epub 2016 Mar 17. Br J Radiol. 2016. PMID: 26986457 Free PMC article. Clinical Trial.

8

Breast-conservative surgery followed by radiofrequency ablation of margins decreases the need for a second surgical procedure for close or positive margins.

Rubio IT, Landolfi S, Molla M, Cortes J, Xercavins J. Rubio IT, et al. Among authors: molla m. Clin Breast Cancer. 2014 Oct;14(5):346-51. doi: 10.1016/j.clbc.2014.02.002. Epub 2014 Feb 21. Clin Breast Cancer. 2014. PMID: 24703804 Clinical Trial.

9

Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study.

Miralbell R, Mollà M, Rouzaud M, Hidalgo A, Toscas JI, Lozano J, Sanz S, Ares C, Jorcano S, Linero D, Escudé L. Miralbell R, et al. Among authors: molla m. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):50-7. doi: 10.1016/j.ijrobp.2009.07.1689. Epub 2009 Nov 10. Int J Radiat Oncol Biol Phys. 2010. PMID: 19910135

10

Multiparametric MR imaging to assess response following neoadjuvant systemic treatment in various breast cancer subtypes: Comparison between different definitions of pathologic complete response.

Santamaría G, Bargalló X, Ganau S, Alonso I, Muñoz M, Mollà M, Fernández PL, Prat A. Santamaría G, et al. Among authors: molla m. Eur J Radiol. 2019 Aug;117:132-139. doi: 10.1016/j.ejrad.2019.06.009. Epub 2019 Jun 12. Eur J Radiol. 2019. PMID: 31307638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

430 results

Search Page

Filters